20 related articles for article (PubMed ID: 9058153)
1. Characterisation of the progression of azaserine-induced rat pancreatic adenocarcinoma by proliferative cell nuclear antigen, basement membrane laminin and trypsinogen immunohistochemistry.
Nagy K; Pálfia Z; Réz G
Histochem Cell Biol; 2003 May; 119(5):405-13. PubMed ID: 12743826
[TBL] [Abstract][Full Text] [Related]
2. Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases.
Shen LJ; Zhang HX; Zhang ZJ; Li JY; Chen MQ; Yang WB; Huang R
World J Gastroenterol; 2003 Mar; 9(3):459-62. PubMed ID: 12632497
[TBL] [Abstract][Full Text] [Related]
3. Moving toward an understanding of the metastatic process in hepatocellular carcinoma.
Korn WM
World J Gastroenterol; 2001 Dec; 7(6):777-8. PubMed ID: 11854899
[No Abstract] [Full Text] [Related]
4. Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice.
Wu WY; Xu Q; Shi LC; Zhang WB
World J Gastroenterol; 2000 Apr; 6(2):216-219. PubMed ID: 11819559
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
[TBL] [Abstract][Full Text] [Related]
6. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
7. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
8. The expression of c-kit and proliferating cell nuclear antigen in oval cells of rats with hepatocellular carcinoma.
Fang CH; Zhang W; Zhu XY; Gong JQ; Zhang GQ
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):537-44. PubMed ID: 14627515
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study on early recurrent hepatoma and its treatment].
Nakanishi K; Une Y; Saiki I; Haneda T; Okubo H; Tomioka N; Shimamura T; Kamiyama T; Matsushita M
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():269-72. PubMed ID: 9263514
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25(3):327-32. PubMed ID: 9492824
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
